Medicare Enrolled
Dr. Thomas Sneeringer, DO
Family Medicine · Brookville, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sneeringer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sneeringer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sneeringer
Dr. Thomas Sneeringer is a family medicine specialist in Brookville, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sneeringer performed 1,877 Medicare services across 1,373 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sneeringer received a total of $13,921 from 58 pharmaceutical and/or device companies across 1024 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sneeringer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 9% volume in PA
$13,921 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,877
Medicare services
Top 9% in PA for family medicine
1,373
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~94 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
638 | $78 | $140 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
336 | $8 | $8 |
| Annual depression screening | 196 | $18 | $22 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
176 | $124 | $157 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
139 | $24 | $25 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
135 | $72 | $80 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
35 | $46 | $125 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
33 | $24 | $25 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
30 | $137 | $190 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
29 | $281 | $340 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
23 | $40 | $50 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
18 | $39 | $90 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
17 | $13 | $60 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
17 | $31 | $75 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
16 | $48 | $125 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
15 | $214 | $280 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
13 | $5 | $15 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
11 | $150 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,921
Total received (2018-2024)
Avg $1,989/year across 7 years
Top 4% in PA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
1,024
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,921 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,810
2023
$1,871
2022
$1,943
2021
$2,571
2020
$1,890
2019
$1,885
2018
$1,951
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$243
Novo Nordisk Inc
$202
Amgen Inc.
$192
ABBVIE INC.
$154
PFIZER INC.
$102
Phathom Pharmaceuticals, Inc.
$97
Exact Sciences Corporation
$89
Abbott Laboratories
$79
Boehringer Ingelheim Pharmaceuticals, Inc.
$79
SANOFI PASTEUR INC.
$74
Paratek Pharmaceuticals, Inc.
$67
GlaxoSmithKline, LLC.
$65
Bayer Healthcare Pharmaceuticals Inc.
$51
Lilly USA, LLC
$48
Astellas Pharma US Inc
$39
Otsuka America Pharmaceutical, Inc.
$39
E.R. Squibb & Sons, L.L.C.
$37
Janssen Pharmaceuticals, Inc
$32
Supernus Pharmaceuticals, Inc.
$30
Sumitomo Pharma America, Inc.
$23
Mylan Specialty L.P.
$20
AIMMUNE THERAPEUTICS, INC.
$19
SHIELD THERAPEUTICS INC
$16
Dexcom, Inc.
$14
Top 3 companies account for 35.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,567
Novo Nordisk Inc
$1,543
PFIZER INC.
$1,520
GlaxoSmithKline, LLC.
$805
Amgen Inc.
$769
Janssen Pharmaceuticals, Inc
$748
AbbVie Inc.
$650
Boehringer Ingelheim Pharmaceuticals, Inc.
$611
Amarin Pharma Inc.
$424
E.R. Squibb & Sons, L.L.C.
$421
ABBVIE INC.
$409
Lilly USA, LLC
$344
Astellas Pharma US Inc
$306
Merck Sharp & Dohme Corporation
$245
Novartis Pharmaceuticals Corporation
$243
Abbott Laboratories
$243
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$243
Exact Sciences Corporation
$177
Teva Pharmaceuticals USA, Inc.
$171
SANOFI PASTEUR INC.
$159
Allergan, Inc.
$158
Daiichi Sankyo Inc.
$155
Takeda Pharmaceuticals U.S.A., Inc.
$149
Biohaven Pharmaceutical Holding Company Ltd.
$148
Esperion Therapeutics, Inc.
$123
Sumitomo Pharma America, Inc.
$121
Phathom Pharmaceuticals, Inc.
$120
AbbVie, Inc.
$103
Biohaven Pharmaceuticals, Inc.
$101
Bayer Healthcare Pharmaceuticals Inc.
$83
Otsuka America Pharmaceutical, Inc.
$80
SANOFI-AVENTIS U.S. LLC
$77
Tactile Systems Technology Inc
$71
Paratek Pharmaceuticals, Inc.
$67
Bayer HealthCare Pharmaceuticals Inc.
$63
Nestle HealthCare Nutrition Inc.
$54
Eisai Inc.
$53
Medtronic, Inc.
$52
Merck Sharp & Dohme LLC
$50
Dexcom, Inc.
$47
Shire North American Group Inc
$45
Synergy Pharmaceuticals Inc
$42
Allergan Inc.
$34
Radius Health, Inc.
$34
Sunovion Pharmaceuticals Inc.
$30
Supernus Pharmaceuticals, Inc.
$30
Biogen, Inc.
$30
Kowa Pharmaceuticals America, Inc.
$28
Genentech USA, Inc.
$27
Mylan Specialty L.P.
$20
AIMMUNE THERAPEUTICS, INC.
$19
Alexion Pharmaceuticals, Inc.
$19
Apria Healthcare LLC
$17
OPKO Pharmaceuticals, LLC
$17
Lundbeck LLC
$16
SHIELD THERAPEUTICS INC
$16
Purdue Pharma L.P.
$12
Celgene Corporation
$12
Top 3 companies account for 33.3% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADUHELM · ADVAIR · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · Amitiza · Androgel · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BEXSERO · BEYFORTUS · BREO · BREZTRI · BYDUREON · Belviq · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · Cologuard Collection Kit · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · FARXIGA · FASENRA · FLEXITOUCH · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUMIST QUADRIVALENT · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GARDASIL 9 · GEMTESA · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LATUDA · LEQVIO · LINZESS · LYRICA · Livalo · MOUNJARO · MYDAYIS · MYRBETRIQ · Medela · Myrbetriq · NEXLETOL · NEXLIZET · NURTEC ODT · NUZYRA · OFEV · Otezla · Ozempic · PENTACEL · PNEUMOVAX 23 · PRADAXA · PREMARIN · PREVNAR 13 · Prolia · QULIPTA · QVAR · Qelbree · RAYALDEE · REXULTI · ROTATEQ · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYMPROIC · SYNTHROID · Saxenda · Strensiq · Synthroid · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULANCE · TRULICITY · Tresiba · Trintellix · Trulance · Tymlos · UBRELVY · VENASEAL · VIBERZI · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · Xofluza · YUPELRI · ZENPEP · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for family medicine in PA.
Geographic Context
Family medicine physicians within 10 mi
119
Per 100K population
269.8
County median income
$56,898
Nearest hospital
PENN HIGHLANDS BROOKVILLE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sneeringer is a clinical cardiology specialist, with above-average Medicare volume (top 9% in PA), with low-engagement industry engagement in the top 4% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sneeringer experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Sneeringer performed 638 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sneeringer receive payments from pharmaceutical companies?
Yes. Dr. Sneeringer received a total of $13,921 from 58 companies across 1,024 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sneeringer's costs compare to other family medicine physicians in Brookville?
Dr. Sneeringer's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sneeringer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Brookville
Browse family medicine physicians in Brookville ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in PA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in PA
Which PA family medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology